Freitag Gregory Gene 4
4 · Axogen, Inc. · Filed Jun 6, 2024
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Freitag Gregory Gene
DirectorCFO
Transactions
- Exercise/Conversion
Common Stock
2024-06-04+11,904→ 283,498 total - Exercise/Conversion
Restricted Stock Units
2024-06-04−11,904→ 0 total→ Common Stock (11,904 underlying)
Footnotes (2)
- [F1]Effective June 4, 2024, the Board of Directors accelerated the vesting of outstanding and unvested equity totaling 11, 904 shares of common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.